Carré M - Search Results

1

Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms.

Ariey-Bonnet J, Berges R, Montero MP, Mouysset B, Piris P, Muller K, Pinna G, Failes TW, Arndt GM, Morando P, Baeza-Kallee N, Colin C, Chinot O, Braguer D, Morelli X, André N, Carré M, Tabouret E, Figarella-Branger D, Le Grand M, Pasquier E. Ariey-Bonnet J, et al. Among authors: carre m. EBioMedicine. 2023 Sep;95:104752. doi: 10.1016/j.ebiom.2023.104752. Epub 2023 Aug 10. EBioMedicine. 2023. PMID: 37572644 Free PMC article.

2

Involvement of microtubules and mitochondria in the antagonism of arsenic trioxide on paclitaxel-induced apoptosis.

Carré M, Carles G, André N, Douillard S, Ciccolini J, Briand C, Braguer D. Carré M, et al. Biochem Pharmacol. 2002 May 15;63(10):1831-42. doi: 10.1016/s0006-2952(02)00922-x. Biochem Pharmacol. 2002. PMID: 12034367

3

Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel.

Carré M, André N, Carles G, Borghi H, Brichese L, Briand C, Braguer D. Carré M, et al. J Biol Chem. 2002 Sep 13;277(37):33664-9. doi: 10.1074/jbc.M203834200. Epub 2002 Jun 26. J Biol Chem. 2002. PMID: 12087096 Free article.

4

Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells.

André N, Carré M, Brasseur G, Pourroy B, Kovacic H, Briand C, Braguer D. André N, et al. Among authors: carre m. FEBS Lett. 2002 Dec 4;532(1-2):256-60. doi: 10.1016/s0014-5793(02)03691-8. FEBS Lett. 2002. PMID: 12459501 Free article.

5

Antiangiogenic activity of paclitaxel is associated with its cytostatic effect, mediated by the initiation but not completion of a mitochondrial apoptotic signaling pathway.

Pasquier E, Carré M, Pourroy B, Camoin L, Rebaï O, Briand C, Braguer D. Pasquier E, et al. Among authors: carre m. Mol Cancer Ther. 2004 Oct;3(10):1301-10. Mol Cancer Ther. 2004. PMID: 15486197

6

[Antimitochondrial agents: a new class of anticancer agents].

André N, Rome A, Carré M; Société Francophone de Recherche en Pédiatrie (SFRP). André N, et al. Among authors: carre m. Arch Pediatr. 2006 Jan;13(1):69-75. doi: 10.1016/j.arcped.2005.10.003. Epub 2005 Nov 16. Arch Pediatr. 2006. PMID: 16298120 Review. French.

7

Bcl-2 down-regulation and tubulin subtype composition are involved in resistance of ovarian cancer cells to vinflunine.

Estève MA, Carré M, Bourgarel-Rey V, Kruczynski A, Raspaglio G, Ferlini C, Braguer D. Estève MA, et al. Among authors: carre m. Mol Cancer Ther. 2006 Nov;5(11):2824-33. doi: 10.1158/1535-7163.MCT-06-0277. Mol Cancer Ther. 2006. PMID: 17121929

8

Microtubules in apoptosis induction: are they necessary?

Estève MA, Carré M, Braguer D. Estève MA, et al. Among authors: carre m. Curr Cancer Drug Targets. 2007 Dec;7(8):713-29. doi: 10.2174/156800907783220480. Curr Cancer Drug Targets. 2007. PMID: 18220532 Review.

9

Transcriptional down-regulation of Bcl-2 by vinorelbine: identification of a novel binding site of p53 on Bcl-2 promoter.

Bourgarel-Rey V, Savry A, Hua G, Carré M, Bressin C, Chacon C, Imbert J, Braguer D, Barra Y. Bourgarel-Rey V, et al. Among authors: carre m. Biochem Pharmacol. 2009 Nov 1;78(9):1148-56. doi: 10.1016/j.bcp.2009.06.025. Epub 2009 Jun 23. Biochem Pharmacol. 2009. PMID: 19555669 Free article.

10

Olesoxime prevents microtubule-targeting drug neurotoxicity: selective preservation of EB comets in differentiated neuronal cells.

Rovini A, Carré M, Bordet T, Pruss RM, Braguer D. Rovini A, et al. Among authors: carre m. Biochem Pharmacol. 2010 Sep 15;80(6):884-94. doi: 10.1016/j.bcp.2010.04.018. Epub 2010 Apr 22. Biochem Pharmacol. 2010. PMID: 20417191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page